Brandes Investment Partners’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-28,500	Closed	-$70K	–	142
2017 Q2	$70K	Hold	28,500	–	–	﹤0.01%	175
2017 Q1	$66K	Buy	+28,500	New	+$66K	﹤0.01%	187